Key result
Combined ABCA1 and PPARA polymorphisms are linked to ~4-fold higher risk of premature CAD.
Case-Control (n=358)
OBJECTIVE: Progression of atherosclerosis, the main reason of cardiovascular diseases, depends on multiple genetic and environmental factors. Polymorphic variants of genes involved in the lipids metabolism may genetically differentiate human populations and determine a susceptibility to the disease. The aim of the present study was to evaluate a possible interaction between R219K polymorphism of ABCA1 gene and G > C polymorphism in intron 7 of PPARA gene in determining the risk of the CAD. METHODS: We studied 358 subjects: 178 patients with angiographically confirmed CAD and 180 blood donors without history of CAD. Polymorphisms were genotyped using the PCR-RFLP method. RESULTS: In spite of a small or no correlation between single polymorphism and CAD we observed that the frequencies of AA + GC,CC genotype pattern (ABCA1 and PPARA gene) were significantly higher in CAD group than in controls. OR values were especially high in multiple logistic regression and were higher for male subgroups. The synergy index value equals 3.98 and indicates a quite strong synergistic effect between the analysed polymorphisms. We also observed that C allele carriers of PPARA gene had a significantly lower total and LDL-cholesterol level. CONCLUSION: The present study shows that R219K polymorphism of ABCA1 gene and G > C polymorphism in intron 7 of PPARA gene act cumulatively and synergistically in determining the risk of premature CAD.
No takes yet. Share an insight, caveat, or question.
Balcerzyk et al. (2007) conducted a case-control in Premature coronary artery disease (n=358). ABCA1 R219K and PPARA intron 7 G>C polymorphisms (AA + GC,CC genotype pattern) vs. Blood donors without history of CAD / other genotype patterns was evaluated on Premature coronary artery disease (Synergy index 3.98). ABCA1 R219K and PPARA intron 7 G>C polymorphisms acted synergistically to increase the risk of premature coronary artery disease (synergy index = 3.98).
Synapse has enriched 5 related papers. Consider them for comparative context: